[Photo] SK Chemicals wins FDA approval for Alzheimer’s patch

South Korean pharmaceutical company SK Chemicals, an affiliate of the SK Group conglomerate, has won FDA approval for its drug for treating Alzheimer’s disease. SK Chemicals’ patch-type drug became the first Alzheimer’s drugs developed by a South Korean company to receive FDA approval, paving the way for the drug to infiltrate the US market. Patients merely have to attach the patch to their skin once a day for continuous delivery of the drug. The drug, SID710, is SK Chemicals’ version of Novartis’ Exelon Patch. (SK Chemicals)